![Kjell Rensfeldt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kjell Rensfeldt worked as a Principal at Biogen, Inc. and Q-Med AB. He also worked at Moberg Pharma AB from 2007 to 2018, where he held the position of Chief Medical Officer & VP-Clinical Development from 2012 to 2013.
Ehemalige bekannte Positionen von Kjell Rensfeldt
| Unternehmen | Position | Ende |
|---|---|---|
| MOBERG PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 13.08.2018 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Health Technology |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
